AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ECO ANIMAL HEALTH GROUP PLC

Report Publication Announcement Jul 21, 2023

7612_10-k_2023-07-21_d6fbb622-119c-4174-b8a3-2fd69d859266.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8538G

Eco Animal Health Group PLC

21 July 2023

21 July 2023

ECO Animal Health Group pc ("ECO", the "Company" or the "Group")

(AIM: EAH)

Posting of the Annual Report and Accounts

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, announces the publication of its Annual Report and Accounts for the year ended 31 March 2023 on the Company's website: https://www.ecoanimalhealthgroupplc.com/investor-relations/

The Annual Report and Accounts will be posted today to those shareholders that have elected to receive it by post.

A further announcement regarding the Notice of the Annual General Meeting will be made in due course.

Contacts

ECO Animal Health Group plc

David Hallas (Chief Executive Officer)

Christopher Wilks (Chief Financial Officer)
020 8447 8899
IFC Advisory

Graham Herring

Zach Cohen
020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker)

Philip Davies

George Tzimas

Sam Butcher
020 7496 3000
Investec (Joint Broker)

Gary Clarence

Carlo Spingardi

Lydia Zychowska
020 7597 5970
Equity Development

Hannah Crowe

Matt Evans
020 7065 2692

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSUAUVROUUBUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.